| Biliary epithelium and liver B cells exposed to bacteria activate intrahepatic MAIT cells through MR1 HC Jeffery, B Van Wilgenburg, A Kurioka, K Parekh, K Stirling, S Roberts, ... Journal of hepatology 64 (5), 1118-1127, 2016 | 224 | 2016 |
| Neutrophils induce paracrine telomere dysfunction and senescence in ROS‐dependent manner A Lagnado, J Leslie, MH Ruchaud‐Sparagano, S Victorelli, P Hirsova, ... The EMBO journal 40 (9), e106048, 2021 | 167 | 2021 |
| Neutrophils as potential therapeutic targets in hepatocellular carcinoma D Geh, J Leslie, R Rumney, HL Reeves, TG Bird, DA Mann Nature Reviews Gastroenterology & Hepatology 19 (4), 257-273, 2022 | 150 | 2022 |
| CXCR2 inhibition enables NASH-HCC immunotherapy J Leslie, JBG Mackey, T Jamieson, E Ramon-Gil, TM Drake, F Fercoq, ... Gut 71 (10), 2093-2106, 2022 | 129 | 2022 |
| Immunomodulatory effects of lenvatinib plus anti–programmed cell death protein 1 in mice and rationale for patient enrichment in hepatocellular carcinoma L Torrens, C Montironi, M Puigvehí, A Mesropian, J Leslie, PK Haber, ... Hepatology 74 (5), 2652-2669, 2021 | 118 | 2021 |
| NAFLD-associated HCC: progress and opportunities D Geh, QM Anstee, HL Reeves Journal of Hepatocellular Carcinoma, 223-239, 2021 | 60 | 2021 |
| Hepatocellular carcinoma in non-alcoholic fatty liver disease—A review of an emerging challenge facing clinicians D Geh, DM Manas, HL Reeves Hepatobiliary surgery and nutrition 10 (1), 59, 2021 | 53 | 2021 |
| Epratuzumab for the treatment of systemic lupus erythematosus D Geh, C Gordon Expert review of clinical immunology 14 (4), 245-258, 2018 | 43 | 2018 |
| No lasting legacy: no change in reporting of women's sports in the British print media with the London 2012 Olympics and Paralympics C Packer, DJ Geh, OW Goulden, AM Jordan, GK Withers, AJ Wagstaff, ... Journal of Public Health 37 (1), 50-56, 2015 | 41 | 2015 |
| Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions J Leslie, D Geh, AM Elsharkawy, DA Mann, M Vacca Journal of hepatology 77 (1), 219-236, 2022 | 33 | 2022 |
| COVID-19 and liver cancer: lost patients and larger tumours D Geh, R Watson, G Sen, JJ French, J Hammond, P Turner, T Hoare, ... BMJ Open Gastroenterology 9 (1), e000794, 2022 | 27 | 2022 |
| Weighing the benefits of hepatocellular carcinoma surveillance against potential harms D Geh, FA Rana, HL Reeves Journal of hepatocellular carcinoma, 23-30, 2019 | 17 | 2019 |
| Immunomodulatory effects of lenvatinib plus anti-PD1 in mice and rationale for patient enrichment in hepatocellular carcinoma. L Torrens, C Montironi, M Puigvehí, A Mesropian, J Leslie, PK Haber, ... Hepatology, 2021, vol. 74, num. 5, p. 2652-2669, 2021 | 16 | 2021 |
| Bacteria exposed biliary epithelium and liver B cells activate intrahepatic MAIT cells in an MR1-dependent manner H Jeffery, B van Wilgenburg, A Kurioka, K Parekh, K Stirling, S Roberts, ... Journal of Hepatology 64 (5), 2015 | 14 | 2015 |
| Randomized controlled study of the prediction of diminutive/small colorectal polyp histology using didactic versus computer‐based self‐learning module in gastroenterology trainees SCL Smith, J Saltzman, UN Shivaji, BC Lethebe, R Cannatelli, ... Digestive Endoscopy 31 (5), 535-543, 2019 | 13 | 2019 |
| Latent cytomegalovirus infection and previous capsular polysaccharide vaccination predict poor vaccine responses in older adults, independent of chronic kidney disease N Wall, A Godlee, D Geh, C Jones, S Faustini, R Harvey, R Penn, ... Clinical Infectious Diseases 73 (4), e880-e889, 2021 | 10 | 2021 |
| ST3 beta-galactoside alpha-2, 3-sialyltransferase 1 (ST3Gal1) synthesis of Siglec ligands mediates anti-tumour immunity in prostate cancer R Garnham, D Geh, R Nelson, E Ramon-Gil, L Wilson, EN Schmidt, ... Communications Biology 7 (1), 276, 2024 | 9 | 2024 |
| Sulfatase-2 from cancer associated fibroblasts: An environmental target for hepatocellular carcinoma? MYW Zaki, SF Alhasan, R Shukla, M McCain, M Laszczewska, D Geh, ... Liver Cancer 11 (6), 540-557, 2022 | 8 | 2022 |
| c‐Rel–dependent Chk2 signaling regulates the DNA damage response limiting hepatocarcinogenesis J Leslie, JE Hunter, A Collins, A Rushton, LG Russell, E Ramon‐Gil, ... Hepatology 78 (4), 1050-1063, 2023 | 7 | 2023 |
| Harnessing neutrophil plasticity for HCC immunotherapy E Ramon-Gil, D Geh, J Leslie Essays in Biochemistry 67 (6), 941-955, 2023 | 5 | 2023 |
